Asthma Therapeutics Market to reach 21.7 Billion by 2020

1
Asthma Therapeutics in Major Developed Markets to
2020- Personalized Treatment for Severe Asthma to
Drive Market Growth despite Patent Expirations
Published on 28 February, 2015 Number of
pages 142 Single User Price 4995
The Asthma Therapeutics Market is forecast to
grow marginally over the forecast period across
the top eight developed nations, from 18.4
billion in 2013 to a projected value of 21.7
billion by 2020 at a Compound Annual Growth Rate
(CAGR) of 2.4.
2
Summary of the ReportMarketIntelReports
Research, a leading business intelligence
provider, has released its latest research
report,"Asthma Therapeutics in Major Developed
Markets to 2020 - Personalized Treatment for
Severe Asthma to Drive Market Growth despite
Patent Expirations".The Asthma Therapeutics
Market is forecast to grow marginally over the
forecast period across the top eight developed
nations, from 18.4 billion in 2013 to a
projected value of 21.7 billion by 2020 at a
Compound Annual Growth Rate (CAGR) of 2.4. This
is in spite of generic erosion facing several of
the leading asthma brands, such as Advair
(fluticasone propionate/salmeterol xinafoate),
Symbicort (budesonide/formoterol fumarate) and
Xolair (omalizumab), and is a consequence of new
market entrants and rising disease
prevalence. The global prevalence of asthma is
significant, believed to affect approximately 300
million people worldwide. This burden is
predicted to increase in future, reaching 400
million by 2025. Although the majority of asthma
patients are able to manage their symptoms
effectively using currently marketed products,
some remain inadequately controlled with these
same products. This unmet need, coupled with
rising global prevalence, has resulted in strong
industry interest.
Click Here To Check Complete Report
3
Scope of the Report The report covers and
includes - - An introduction to asthma,
including discussion of disease epidemiology,
etiology pathophysiology, symptoms, diagnosis,
and treatment, with clinical data for drugs
featured in the current treatment algorithm
discussed in detail- In-depth analysis of the
current marketed products landscape, including
product profiles of the main drugs used and heat
maps that compare their safety and efficacy
parameters- Comprehensive analysis of the asthma
pipeline by phase of development, molecule type,
and molecular target and novelty, and comparative
analysis of the most promising late-stage
pipeline drugs, as well as heat maps and a
competitor matrix that compares safety and
efficacy parameters- Additional in-depth
analysis of the asthma clinical trials landscape,
including trends in size, duration and failure
rate
Download Sample Brochure
4

• Reasons to buy
• The report will assist business development and
  enable marketing executives to strategize their
  product launches by allowing them to -
• Gain a comprehensive understanding of asthma,
  including diagnosis, disease severity, and
  treatment algorithms
• Understand the current asthma marketed products
  landscape and recognize the dominant therapeutic
  agents and pharmaceutical players involved
• Identify trends, developments, and prominent
  molecule types and molecular targets within the
  asthma pipeline
• Gain an appreciation of the clinical and
  commercial aspects of the most promising
  late-stage pipeline molecules and their potential
  competitive impact on the future market
• Consider market opportunities and potential risks
  by examining trends in asthma clinical trial
  size, duration and failure rate, phase of
  development, molecule type, and molecular target
• Observe projections for treatment usage patterns,
  annual therapy costs, and market growth in the
  eight major markets and understand reasons for
  variance in projected patterns of growth

Make an Inquiry Before Buying
5
Asthma Therapeutics in Major Developed Markets to
2020- Personalized Treatment for Severe Asthma to
Drive Market Growth despite Patent Expirations
A detailed qualitative analysis of the factors
responsible for driving and restraining growth of
the Asthma Therapeutics Market are provided in
the report.
Contact 1-302-684-6088 sales_at_marketintelreports.c
om www.marketintelreports.com
Click here to order a copy of Asthma
Therapeutics Market Report